Afriplex is a South African company rooted in the development and manufacturing of botanical extracts, complementary medicines and food & beverage product solutions.

info@afriplex.co.za

+27 (0)21 872 4976

+27 86 578 1305

Trading hours: Monday - Thursday (08:00-17:00) Fridays (08:00-16:30)

Top
afriplex-grt-rooibos

AFRIPLEX RELEASING FIRST SA-DEVELOPED ROOIBOS API

Afriplex (Pty) Ltd, regarded one of the leaders in API development and production in South Africa, has partnered with the South African Medical Research Council (SAMRC) and Agricultural Research Council (ARC) to develop Afriplex GRT™. The end result is Afriplex GRT™, an active pharmaceutical ingredient (API) that will use naturally occurring flavonoid compounds found in rooibos to target specific metabolic syndrome-related dysfunctions in the body. Afriplex GRT™ is regarded as the first of its kind to be developed in South Africa. According to the World Health Organisation (WHO), the number of people with diabetes has risen from 108 million in 1980...

AFRIPLEX-LAUNCHES-APIMF-DEVELOPMENT-PROGRAM

AFRIPLEX LAUNCHES APIMF DEVELOPMENT PROGRAM

Afriplex is excited to announce a unique range of active pharmaceutical ingredients (API), supported by fully developed active pharmaceutical ingredient master files (APIMF). By utilising our research and development capabilities, we've expanded into APIMF development to support our range of API's such as Folicin A/T and Afriplex GRT. An APIMF describes the preparation, control and stability of the API and forms the basis of Module 3.2.S of the Common Technical Document (CTD). An API can be described as the drug substance or the active ingredient of a pharmaceutical product. Afriplex is excited to have launched this program and by working closely with...

Copyrighted Image